Annual Accounts Payable
$102.75 M
+$11.99 M+13.21%
31 December 2023
Summary:
Jazz Pharmaceuticals annual accounts payable is currently $102.75 million, with the most recent change of +$11.99 million (+13.21%) on 31 December 2023. During the last 3 years, it has risen by +$75.81 million (+281.33%). JAZZ annual accounts payable is now at all-time high.JAZZ Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$85.42 M
-$11.67 M-12.02%
30 September 2024
Summary:
Jazz Pharmaceuticals quarterly accounts payable is currently $85.42 million, with the most recent change of -$11.67 million (-12.02%) on 30 September 2024. Over the past year, it has dropped by -$24.43 million (-22.23%). JAZZ quarterly accounts payable is now -31.91% below its all-time high of $125.45 million, reached on 31 March 2023.JAZZ Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JAZZ Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +13.2% | -22.2% |
| 3 y3 years | +281.3% | +33.9% |
| 5 y5 years | +153.1% | +21.9% |
JAZZ Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +281.3% | -31.9% | +33.9% |
| 5 y | 5 years | at high | +281.3% | -31.9% | +217.0% |
| alltime | all time | at high | +4661.4% | -31.9% | +3858.5% |
Jazz Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $85.42 M(-12.0%) |
| June 2024 | - | $97.10 M(+19.9%) |
| Mar 2024 | - | $80.98 M(-21.2%) |
| Dec 2023 | $102.75 M(+13.2%) | $102.75 M(-6.5%) |
| Sept 2023 | - | $109.85 M(+11.6%) |
| June 2023 | - | $98.43 M(-21.5%) |
| Mar 2023 | - | $125.45 M(+38.2%) |
| Dec 2022 | $90.76 M(-9.5%) | $90.76 M(-11.2%) |
| Sept 2022 | - | $102.25 M(+37.9%) |
| June 2022 | - | $74.16 M(+1.1%) |
| Mar 2022 | - | $73.34 M(-26.9%) |
| Dec 2021 | $100.30 M(+272.2%) | $100.30 M(+57.2%) |
| Sept 2021 | - | $63.81 M(-1.6%) |
| June 2021 | - | $64.83 M(-16.6%) |
| Mar 2021 | - | $77.74 M(+188.5%) |
| Dec 2020 | $26.95 M(-41.1%) | $26.95 M(-59.8%) |
| Sept 2020 | - | $67.06 M(+34.0%) |
| June 2020 | - | $50.04 M(-24.5%) |
| Mar 2020 | - | $66.31 M(+45.0%) |
| Dec 2019 | $45.73 M(+12.6%) | $45.73 M(-34.8%) |
| Sept 2019 | - | $70.10 M(-14.7%) |
| June 2019 | - | $82.22 M(+92.7%) |
| Mar 2019 | - | $42.67 M(+5.1%) |
| Dec 2018 | $40.60 M(+66.6%) | $40.60 M(+8.6%) |
| Sept 2018 | - | $37.37 M(+19.1%) |
| June 2018 | - | $31.38 M(-33.1%) |
| Mar 2018 | - | $46.93 M(+92.6%) |
| Dec 2017 | $24.37 M(+8.7%) | $24.37 M(-18.7%) |
| Sept 2017 | - | $29.97 M(+5.1%) |
| June 2017 | - | $28.53 M(-2.1%) |
| Mar 2017 | - | $29.14 M(+30.0%) |
| Dec 2016 | $22.41 M(+2.8%) | $22.41 M(+27.2%) |
| Sept 2016 | - | $17.63 M(-37.9%) |
| June 2016 | - | $28.41 M(-12.9%) |
| Mar 2016 | - | $32.62 M(+49.6%) |
| Dec 2015 | $21.81 M | $21.81 M(-25.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2015 | - | $29.12 M(+10.3%) |
| June 2015 | - | $26.41 M(-3.3%) |
| Mar 2015 | - | $27.32 M(+8.7%) |
| Dec 2014 | $25.13 M(+19.6%) | $25.13 M(-15.3%) |
| Sept 2014 | - | $29.67 M(-8.9%) |
| June 2014 | - | $32.55 M(-55.1%) |
| Mar 2014 | - | $72.54 M(+245.3%) |
| Dec 2013 | $21.00 M(+32.2%) | $21.00 M(-6.4%) |
| Sept 2013 | - | $22.43 M(+10.1%) |
| June 2013 | - | $20.37 M(-35.6%) |
| Mar 2013 | - | $31.63 M(+99.1%) |
| Dec 2012 | $15.89 M(+209.7%) | $15.89 M(-22.6%) |
| Sept 2012 | - | $20.54 M(-40.5%) |
| June 2012 | - | $34.51 M(+152.1%) |
| Mar 2012 | - | $13.69 M(+166.9%) |
| Dec 2011 | $5.13 M(+68.2%) | $5.13 M(-39.4%) |
| Sept 2011 | - | $8.46 M(+81.4%) |
| June 2011 | - | $4.67 M(+27.9%) |
| Mar 2011 | - | $3.65 M(+19.6%) |
| Dec 2010 | $3.05 M(+41.3%) | $3.05 M(-52.4%) |
| June 2010 | - | $6.40 M(+64.8%) |
| Mar 2010 | - | $3.88 M(+80.0%) |
| Dec 2009 | $2.16 M(-62.4%) | $2.16 M(-58.8%) |
| Sept 2009 | - | $5.24 M(+28.6%) |
| June 2009 | - | $4.07 M(-10.5%) |
| Mar 2009 | - | $4.55 M(-20.6%) |
| Dec 2008 | $5.74 M(+100.8%) | $5.74 M(-13.3%) |
| Sept 2008 | - | $6.61 M(-22.4%) |
| June 2008 | - | $8.52 M(-4.4%) |
| Mar 2008 | - | $8.91 M(+212.1%) |
| Dec 2007 | $2.86 M(-47.5%) | $2.86 M(-0.6%) |
| Sept 2007 | - | $2.87 M(-32.7%) |
| June 2007 | - | $4.27 M(+35.7%) |
| Mar 2007 | - | $3.15 M(-42.2%) |
| Dec 2006 | $5.44 M(+13.7%) | $5.44 M(+13.7%) |
| Dec 2005 | $4.79 M | $4.79 M |
FAQ
- What is Jazz Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals annual accounts payable year-on-year change?
- What is Jazz Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly accounts payable year-on-year change?
What is Jazz Pharmaceuticals annual accounts payable?
The current annual accounts payable of JAZZ is $102.75 M
What is the all time high annual accounts payable for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high annual accounts payable is $102.75 M
What is Jazz Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, JAZZ annual accounts payable has changed by +$11.99 M (+13.21%)
What is Jazz Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of JAZZ is $85.42 M
What is the all time high quarterly accounts payable for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high quarterly accounts payable is $125.45 M
What is Jazz Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, JAZZ quarterly accounts payable has changed by -$24.43 M (-22.23%)